Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


IGBA CEO Panel Sets Out Priorities For Supply-Chain Resilience

CEO Advisory Committee Outlines Four Keys To More Predictable Supply

Executive Summary

After a meeting in Vienna, the IGBA’s CEO advisory committee has outlined four key areas in which action is needed to bolster supply-chain security and ensure pandemic prevention, preparedness and response.

You may also be interested in...

IGBA Leaders Open Up Talks With WIPO

The IGBA’s CEO advisory committee of top off-patent industry leaders has met with Daren Tang, director general of the WIPO, to discuss the importance of a balanced global intellectual property regime.

Fresenius Pushes Kabi Even Higher As Former Sandoz Exec Named CEO

The Fresenius group spoke at length about its core Fresenius Kabi business during the company’s year-end financial call, not least its under pressure IV drugs in the US.

Sandoz’s Saynor Leads IGBA’s CEO Advisory Committee

Sandoz chief executive Richard Saynor has been named as chair of the IGBA’s CEO advisory committee, which was first convened earlier this year. At the same time, Lupin CEO Vinita Gupta has been made vice-chair.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts